Roka Bioscience Secures $47.5 Million in Series D Financing
January 6, 2012
WARREN, N.J. -- Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of [...]
HORIBA consolidates its U.S. operations
January 6, 2012
HORIBA, Ltd. announced the restructuring of the U.S. subsidiaries, including the merger of 4 U.S. subsidiaries to HORIBA International Corporation’s affiliate, HORIBA Instruments Incorporated which is expected to aggregate the U.S. business structure. This facilitates the business performance and provides further competitive edge in sales in North America which has the largest analytical and measurement [...]
Pacific Biosciences Names Michael W. Hunkapiller Chief Executive Officer
January 6, 2012
MENLO PARK, Calif. – Pacific Biosciences of California, Inc. (NASDAQ:PACB), provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael W. Hunkapiller, Ph.D., as President and Chief Executive Officer effective immediately. He succeeds Hugh Martin, who will remain on the Board of Directors through the company’s next annual meeting of [...]
QIAGEN Launches QIAensemble Decapper Sample Preparation Automation System
January 6, 2012
HILDEN, Germany, and GERMANTOWN, Maryland - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today the launch of the QIAensemble Decapper automation system that will facilitate the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories around the world. This open platform system enables laboratories to [...]
Anachem becomes Exclusive UK Distributor for KAPA Biosystems’ Next-Generation PCR Reagents
January 6, 2012
Anachem Ltd., a METTLER TOLEDO company (Luton, UK) is delighted to announce that it has now been awarded exclusive UK distribution rights for the novel range of molecular engineered reagents from KAPA Biosystems Inc., (Woburn, MA USA). Having become a trusted supplier to UK Life Science Research customers over the last 40 years, Anachem provides [...]
nanoTherics Launches magnefect DUO Transfection Devices – New, Flexible Oscillating
January 6, 2012
nanoTherics, a UK-based scientific medical research devices company, is pleased to announce launch of the magnefect-nano II DUO and the magnefect-LT DUO transfection systems which enable up to 192 transfection experiments to be performed in parallel. These new, compact devices offer gene transfection with improved efficiencies and cell viabilities, even with a range of difficult [...]
Thermo Fisher Scientific Introduces Unity Lab Services
January 6, 2012
WALTHAM, Mass.-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today introduced Unity™ Lab Services, a new offering that combines product and laboratory support services to create a single solution for customers to optimize productivity and reduce their total cost of laboratory operations. Unity Lab Services represents a range of capabilities, [...]
Thermo Fisher Scientific Creates New iPhone App for Selecting Bottles and Carboys
January 6, 2012
ROCHESTER, N.Y. – Thermo Fisher Scientific Inc., the world leader in serving science, has created a free iPhone and Android app for the selection of Thermo Scientific Nalgene bottles, carboys and vials. Based on their specific laboratory needs, users simply insert a Nalgene® catalog number or search terms and the intuitive app recommends the most [...]
Transgenomic Announces $3 Million Convertible Note Financing
January 6, 2012
OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has entered into a Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”) in the aggregate amount of $3.0 million with entities (the “Investors”) associated with Third Security, LLC, a leading life sciences investment firm. “We are very pleased with the additional investment by Third [...]
Agendia Signs Contract with Blue Shield of California
January 5, 2012
IRVINE, Calif. and AMSTERDAM -- Agendia, an innovative molecular cancer diagnostics company, today announced that the company has signed a contract with Blue Shield of California, making Agendia an in-network provider. The move paves the way for future in-network coverage for MammaPrint® and other Agendia tests by Blue Cross affiliates across the United States. Developed [...]
